Immunological abnormalities in patients with early-onset ataxia with ocular motor apraxia and hypoalbuminemia

Copyright © 2021 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 229(2021) vom: 01. Aug., Seite 108776
1. Verfasser: Kato, Tamaki (VerfasserIn)
Weitere Verfasser: Tamura, Yoshiteru, Matsumoto, Hiroshi, Kobayashi, Osamu, Ishiguro, Hideaki, Ogawa, Masaya, Tsujikawa, Koyo, Hasegawa, Yasuhiro, Sakamoto, Mitsuhiro, Konagaya, Masaaki, Houzen, Hideki, Takagi, Masatoshi, Imai, Kohsuke, Morio, Tomohiro, Yokoseki, Akio, Onodera, Osamu, Nonoyama, Shigeaki
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't DNA double-strand break repair DNA single-strand break repair Early-onset ataxia with ocular motor apraxia and hypoalbuminemia (EAOH) Immunological abnormalities Radiosensitivity APTX protein, human DNA-Binding Proteins Nuclear Proteins
LEADER 01000naa a22002652 4500
001 NLM326663061
003 DE-627
005 20231225195059.0
007 cr uuu---uuuuu
008 231225s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2021.108776  |2 doi 
028 5 2 |a pubmed24n1088.xml 
035 |a (DE-627)NLM326663061 
035 |a (NLM)34118401 
035 |a (PII)S1521-6616(21)00113-3 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Kato, Tamaki  |e verfasserin  |4 aut 
245 1 0 |a Immunological abnormalities in patients with early-onset ataxia with ocular motor apraxia and hypoalbuminemia 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 16.09.2021 
500 |a Date Revised 16.09.2021 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2021 Elsevier Inc. All rights reserved. 
520 |a Early-onset ataxia with ocular motor apraxia and hypoalbuminemia (EAOH) is a neurodegenerative disorder caused by mutation in the aprataxin (APTX)-coding gene APTX, which is involved in DNA single-strand break repair (SSBR). The neurological abnormalities associated with EAOH are similar to those observed in patients with ataxia-telangiectasia. However, the immunological abnormalities in patients with EAOH have not been described. In this study, we report that EAOH patients have immunological abnormalities, including lymphopenia; decreased levels of CD4+ T-cells, CD8+ T-cells, and B-cells; hypogammaglobulinemia; low T-cell recombination excision circles and kappa-deleting element recombination circles; and oligoclonality of T-cell receptor β-chain variable repertoire. These immunological abnormalities vary among the EAOH patients. Additionally, mild radiosensitivity in the lymphocytes obtained from the patients with EAOH was demonstrated. These findings suggested that the immunological abnormalities and mild radiosensitivity evident in patients with EAOH could be probably caused by the DNA repair defects 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a DNA double-strand break repair 
650 4 |a DNA single-strand break repair 
650 4 |a Early-onset ataxia with ocular motor apraxia and hypoalbuminemia (EAOH) 
650 4 |a Immunological abnormalities 
650 4 |a Radiosensitivity 
650 7 |a APTX protein, human  |2 NLM 
650 7 |a DNA-Binding Proteins  |2 NLM 
650 7 |a Nuclear Proteins  |2 NLM 
700 1 |a Tamura, Yoshiteru  |e verfasserin  |4 aut 
700 1 |a Matsumoto, Hiroshi  |e verfasserin  |4 aut 
700 1 |a Kobayashi, Osamu  |e verfasserin  |4 aut 
700 1 |a Ishiguro, Hideaki  |e verfasserin  |4 aut 
700 1 |a Ogawa, Masaya  |e verfasserin  |4 aut 
700 1 |a Tsujikawa, Koyo  |e verfasserin  |4 aut 
700 1 |a Hasegawa, Yasuhiro  |e verfasserin  |4 aut 
700 1 |a Sakamoto, Mitsuhiro  |e verfasserin  |4 aut 
700 1 |a Konagaya, Masaaki  |e verfasserin  |4 aut 
700 1 |a Houzen, Hideki  |e verfasserin  |4 aut 
700 1 |a Takagi, Masatoshi  |e verfasserin  |4 aut 
700 1 |a Imai, Kohsuke  |e verfasserin  |4 aut 
700 1 |a Morio, Tomohiro  |e verfasserin  |4 aut 
700 1 |a Yokoseki, Akio  |e verfasserin  |4 aut 
700 1 |a Onodera, Osamu  |e verfasserin  |4 aut 
700 1 |a Nonoyama, Shigeaki  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 229(2021) vom: 01. Aug., Seite 108776  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:229  |g year:2021  |g day:01  |g month:08  |g pages:108776 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2021.108776  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 229  |j 2021  |b 01  |c 08  |h 108776